Lyka Labs Limited — Others, 30-06-2025: Disclosure under SEBI Takeover Regulations

Ipca Laboratories has confirmed that the promoters and persons acting in concert have not created any encumbrance on their equity shares for the financial year ended March 31, 2025. This assurance on unencumbered shareholding underscores promoter confidence and stability, which is a positive signal for investors regarding shareholding security and potential control dynamics.